Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Cebranopadol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 269,920Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tris Pharma to Present Positive Phase 3 Results for Cebranopadol
    Tris Pharma to Present Positive Phase 3 Results for Cebranopadol

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501204234/en/Tris-Pharma-to-Unveil-Positive-Phase-3-Results-including-a-Strong-Safety-Profile-Showcasing-the-Potential-of-Cebranopadol-an-Investigational-First-in-Class-Dual-NMR-Agonist-for-the-Treatment-of-Pain-at-the-2025-ASRA-Annual-Meeting

    BUSINESSWIRE
    01 May 2025
    Share Share
    Tris Pharma to Present New Data at AAPM PainConnect Annual Meeting
    Tris Pharma to Present New Data at AAPM PainConnect Annual Meeting

    01 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250401157017/en/Tris-Pharma-to-Present-New-Data-at-AAPM-PainConnect-Annual-Meeting-and-Showcase-Potential-of-Cebranopadol-a-First-in-Class-Investigational-Dual-NMR-Agonist-for-the-Treatment-of-Pain

    BUSINESSWIRE
    01 Apr 2025
    Share Share
    Tris Reports Positive Ph3 Alleviate-2 Data For Cebranopadol
    Tris Reports Positive Ph3 Alleviate-2 Data For Cebranopadol

    06 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250306271136/en

    BUSINESSWIRE
    06 Mar 2025
    Share Share
    Tris shows its opioid alternative is less likely to be abused
    Tris shows its opioid alternative is less likely to be abused

    28 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tris-builds-clinical-case-opioid-alternative-showing-pain-drug-less-likely-be-abused

    FIERCE BIOTECH
    28 Jan 2025
    Share Share
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903523518/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821421996/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share